Literature DB >> 12969930

Eradication of Helicobacter pylori and use of antisecretory drugs: population based cohort study.

Annmarie Lassen1, Jesper Hallas, Ove B Schaffalitzky de Muckadell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969930      PMCID: PMC194092          DOI: 10.1136/bmj.327.7415.603

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Epidemiology. When an entire country is a cohort.

Authors:  L Frank
Journal:  Science       Date:  2000-03-31       Impact factor: 47.728

Review 2.  Search and treat strategy to eliminate Helicobacter pylori associated ulcer disease.

Authors:  W A de Boer; G N Tytgat
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.

Authors:  K E McColl; A Dickson; A El-Nujumi; E El-Omar; A Kelman
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

4.  The Danish prescription registries.

Authors:  D Gaist; H T Sørensen; J Hallas
Journal:  Dan Med Bull       Date:  1997-09

Review 5.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

  5 in total
  1 in total

1.  Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.

Authors:  J Athene Lane; Liam J Murray; Sian Noble; Matthias Egger; Ian M Harvey; Jenny L Donovan; Prakash Nair; Richard F Harvey
Journal:  BMJ       Date:  2006-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.